Search Results - "Flavia, Salvi"

Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes by Fenaux, Pierre, Platzbecker, Uwe, Mufti, Ghulam J, Garcia-Manero, Guillermo, Buckstein, Rena, Santini, Valeria, Díez-Campelo, María, Finelli, Carlo, Cazzola, Mario, Ilhan, Osman, Sekeres, Mikkael A, Falantes, José F, Arrizabalaga, Beatriz, Salvi, Flavia, Giai, Valentina, Vyas, Paresh, Bowen, David, Selleslag, Dominik, DeZern, Amy E, Jurcic, Joseph G, Germing, Ulrich, Götze, Katharina S, Quesnel, Bruno, Beyne-Rauzy, Odile, Cluzeau, Thomas, Voso, Maria-Teresa, Mazure, Dominiek, Vellenga, Edo, Greenberg, Peter L, Hellström-Lindberg, Eva, Zeidan, Amer M, Adès, Lionel, Verma, Amit, Savona, Michael R, Laadem, Abderrahmane, Benzohra, Aziz, Zhang, Jennie, Rampersad, Anita, Dunshee, Diana R, Linde, Peter G, Sherman, Matthew L, Komrokji, Rami S, List, Alan F

“…Luspatercept is a fusion protein aimed at binding TGF-β family members and reducing SMAD2 and SMAD3 signaling in patients with myelodysplasia with ring…”
Get full text

The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale by Gallamini, Andrea, Barrington, Sally F, Biggi, Alberto, Chauvie, Stephane, Kostakoglu, Lale, Gregianin, Michele, Meignan, Michel, Mikhaeel, George N, Loft, Annika, Zaucha, Jan M, Seymour, John F, Hofman, Michael S, Rigacci, Luigi, Pulsoni, Alessandro, Coleman, Morton, Dann, Eldad J, Trentin, Livio, Casasnovas, Olivier, Rusconi, Chiara, Brice, Pauline, Bolis, Silvia, Viviani, Simonetta, Salvi, Flavia, Luminari, Stefano, Hutchings, Martin

“…A retrospective, international, multicenter study was undertaken to assess: (i) the prognostic role of 'interim' positron emission tomography performed during…”
Get full text

Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: results of the REAL07 open-label, multicentre, phase 2 trial by Vitolo, Umberto, Dr, Chiappella, Annalisa, MD, Franceschetti, Silvia, MD, Carella, Angelo Michele, MD, Baldi, Ileana, PhD, Inghirami, Giorgio, Prof, Spina, Michele, MD, Pavone, Vincenzo, MD, Ladetto, Marco, MD, Liberati, Anna Marina, Prof, Molinari, Anna Lia, MD, Zinzani, Pierluigi, Prof, Salvi, Flavia, MD, Fattori, Pier Paolo, MD, Zaccaria, Alfonso, MD, Dreyling, Martin, Prof, Botto, Barbara, MD, Castellino, Alessia, MD, Congiu, Angela, MD, Gaudiano, Marcello, PhD, Zanni, Manuela, MD, Ciccone, Giovannino, MD, Gaidano, Gianluca, Prof, Rossi, Giuseppe, MD

“…Summary Background Up to 40% of elderly patients with untreated diffuse large B-cell lymphoma (DLBCL) given a regimen of rituximab, cyclophosphamide,…”
Get full text

Rituximab plus bendamustine as front-line treatment in frail elderly (>70 years) patients with diffuse large B-cell non-Hodgkin lymphoma: a phase II multicenter study of the Fondazione Italiana Linfomi by Storti, Sergio, Spina, Michele, Pesce, Emanuela Anna, Salvi, Flavia, Merli, Michele, Ruffini, Alessia, Cabras, Giuseppina, Chiappella, Annalisa, Angelucci, Emanuele, Fabbri, Alberto, Liberati, Anna Marina, Tani, Monica, Musuraca, Gerardo, Molinari, Annalia, Petrilli, Maria Pia, Palladino, Carmela, Ciancia, Rosanna, Ferrario, Andrea, Gasbarrino, Cristiana, Monaco, Federico, Fraticelli, Vincenzo, De Vellis, Annalisa, Merli, Francesco, Luminari, Stefano

“…We conducted a phase II study to assess activity and safety profile of bendamustine and rituximab in elderly patients with untreated diffuse large B-cell…”
Get full text

Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial by Oliva, Esther N, Dr, Alati, Caterina, MD, Santini, Valeria, Prof, Poloni, Antonella, PhD, Molteni, Alfredo, MD, Niscola, Pasquale, PhD, Salvi, Flavia, MD, Sanpaolo, Grazia, MD, Balleari, Enrico, MD, Germing, Ulrich, Prof, Fenaux, Pierre, Prof, Stamatoullas, Aspasia, MD, Palumbo, Giuseppe A, MD, Salutari, Prassede, MD, Impera, Stefana, MD, Avanzini, Paolo, MD, Cortelezzi, Agostino, Prof, Liberati, Anna Marina, Prof, Carluccio, Paola, MD, Buccisano, Francesco, MD, Voso, Maria Teresa, MD, Mancini, Stefano, MD, Kulasekararaj, Austin, MD, Morabito, Fortunato, MD, Bocchia, Monica, Prof, Cufari, Patrizia, Dr.ssa, Spiriti, Maria Antonietta Aloe, MD, Santacaterina, Irene, MD, D'Errigo, Maria Grazia, MD, Bova, Irene, MD, Zini, Gina, Prof, Latagliata, Roberto, MD

“…Summary Background In myelodysplastic syndromes, thrombocytopenia is associated with mortality, but treatments in this setting are scarce. We tested whether…”
Get full text

Rituximab, bendamustine, and low-dose cytarabine as induction therapy in elderly patients with mantle cell lymphoma: a multicentre, phase 2 trial from Fondazione Italiana Linfomi by Visco, Carlo, Dr, Chiappella, Annalisa, MD, Nassi, Luca, MD, Patti, Caterina, MD, Ferrero, Simone, MD, Barbero, Daniela, PhD, Evangelista, Andrea, MS, Spina, Michele, MD, Molinari, Annalia, MD, Rigacci, Luigi, MD, Tani, Monica, MD, Rocco, Alice Di, MD, Pinotti, Graziella, MD, Fabbri, Alberto, MD, Zambello, Renato, MD, Finotto, Silvia, MD, Gotti, Manuel, MD, Carella, Angelo M, MD, Salvi, Flavia, MD, Pileri, Stefano A, Prof, Ladetto, Marco, MD, Ciccone, Giovannino, MD, Gaidano, Gianluca, Prof, Ruggeri, Marco, MD, Martelli, Maurizio, Prof, Vitolo, Umberto, MD

“…Summary Background The combination of rituximab, bendamustine, and cytarabine (R-BAC) was highly active in a pilot trial of mantle cell lymphoma, but its use…”
Get full text

Effects of erythropoiesis-stimulating agents on overall survival of International Prognostic Scoring System Low/Intermediate-1 risk, transfusion-independent myelodysplastic syndrome patients: a cohort study by Messa, Emanuela, Gioia, Daniela, Masiera, Elisa, Castiglione, Anna, Ceccarelli, Manuela, Salvi, Flavia, Danise, Paolo, Sanna, Alessandro, Allione, Bernardino, Balleari, Enrico, Poloni, Antonella, Cametti, Giovanni, Ferrero, Dario, Tassara, Rodolfo, Finelli, Carlo, Bonferroni, Margherita, Musto, Pellegrino, Saglio, Giuseppe, Levis, Alessandro, Santini, Valeria

Get full text

A phase II study on the role of gemcitabine plus romidepsin (GEMRO regimen) in the treatment of relapsed/refractory peripheral T-cell lymphoma patients by Pellegrini, Cinzia, Dodero, Anna, Chiappella, Annalisa, Monaco, Federico, Degl'Innocenti, Debora, Salvi, Flavia, Vitolo, Umberto, Argnani, Lisa, Corradini, Paolo, Zinzani, Pier Luigi

“…There is no consensus regarding optimal treatment for peripheral T-cell lymphomas (PTCL), especially in relapsed or refractory cases, which have very poor…”
Get full text

Clinical characteristics of interim-PET negative patients with a positive end PET from the prospective HD08-01 FIL study by Rigacci, Luigi, Puccini, Benedetta, Broccoli, Alessandro, Dona, Manjola, Gotti, Manuel, Evangelista, Andrea, Santoro, Armando, Bonfichi, Maurizio, Re, Alessandro, Spina, Michele, Botto, Barbara, Pulsoni, Alessandro, Pagani, Chiara, Stelitano, Caterina, Salvi, Flavia, Nassi, Luca, Mannelli, Lara, Kovalchuk, Sofia, Gioia, Daniela, Zinzani, Pier Luigi

“…FDG-positron emission tomography (PET) performed early during therapy in advanced Hodgkin lymphoma patients has been confirmed as being important for…”
Get full text

Second-line rituximab, lenalidomide, and bendamustine in mantle cell lymphoma: a phase II clinical trial of the Fondazione Italiana Linfomi by Zaja, Francesco, Ferrero, Simone, Stelitano, Caterina, Ferrari, Angela, Salvi, Flavia, Arcari, Annalisa, Musuraca, Gerardo, Botto, Barbara, Spina, Michele, Cellini, Claudia, Patti, Caterina, Liberati, Anna M, Minotto, Claudia, Pileri, Stefano A, Ceccarelli, Manuela, Volpetti, Stefano, Ferranti, Antonella, Drandi, Daniela, Montechiarello, Elisa, Ladetto, Marco, Carmichael, James, Fanin, Renato

Get full text

Lenalidomide plus cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab is safe and effective in untreated, elderly patients with diffuse large B-cell lymphoma: a phase I study by the Fondazione Italiana Linfomi by Chiappella, Annalisa, Tucci, Alessandra, Castellino, Alessia, Pavone, Vincenzo, Baldi, Ileana, Carella, Angelo Michele, Orsucci, Lorella, Zanni, Manuela, Salvi, Flavia, Liberati, Anna Marina, Gaidano, Gianluca, Bottelli, Chiara, Rossini, Bernardo, Perticone, Sonia, De Masi, Pasqualina, Ladetto, Marco, Ciccone, Giovannino, Palumbo, Antonio, Rossi, Giuseppe, Vitolo, Umberto

“…Despite improvements in standard therapy with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone for patients with untreated, diffuse large…”
Get full text

Epstein-Barr virus reactivation in allogeneic stem cell transplantation is highly related to cytomegalovirus reactivation by Zallio, Francesco, Primon, Valeria, Tamiazzo, Stefania, Pini, Massimo, Baraldi, Anna, Corsetti, Maria T., Gotta, Franca, Bertassello, Claudia, Salvi, Flavia, Rocchetti, Andrea, Levis, Alessandro

“…Monitoring of Epstein–Barr virus (EBV) load and pre‐emptive rituximab is an appropriate approach to prevent post‐transplant lymphoproliferative disease (PTLD)…”
Get full text

Salvage treatment with lenalidomide and dexamethasone in relapsed/refractory mantle cell lymphoma: clinical results and effects on microenvironment and neo-angiogenic biomarkers by ZAJA, Francesco, DE LUCA, Stefano, BALZAROTTI, Monica, BRUSAMOLINO, Ercole, BONFICHI, Maurizio, PILERI, Stefano A, SABATTINI, Elena, VOLPETTI, Stefano, MONAGHEDDU, Chiara, VACCA, Angelo, RIA, Roberto, FANIN, Renato, VITOLO, Umberto, ORSUCCI, Lorella, LEVIS, Alessandro, SALVI, Flavia, RUSCONI, Chiara, RAVELLI, Erika, TUCCI, Alessandra, BOTTELLI, Chiara

“…Preclinical studies have highlighted the activity of lenalidomide in mantle cell lymphoma and its anti-proliferative synergy with dexamethasone. In this…”
Get full text

PBSC mobilization in lymphoma patients: analysis of risk factors for collection failure and development of a predictive score based on the kinetics of circulating CD34+ cells and WBC after chemotherapy and G-CSF mobilization by Rossi, Giuseppe, Skert, Cristina, Morello, Enrico, Almici, Camillo, Arcaini, Luca, Basilico, Claudia, Cavalli, Lara, Botto, Barbara, Castelli, Andrea, Pica, Gianmatteo, Ripamonti, Francesco, Salvi, Flavia, Carella, Angelo M., Gaidano, Gianluca, Levis, Alessandro, Nosari, Annamaria, Russo, Domenico, Vitolo, Umberto

“…Autologous stem cell transplantation (ASCT) is a potentially curative treatment of lymphoma, but peripheral blood stem cell (PBSC) mobilization fails in some…”
Get full text

Dose-dense and high-dose chemotherapy plus rituximab with autologous stem cell transplantation for primary treatment of diffuse large B-cell lymphoma with a poor prognosis: a phase II multicenter study by Vitolo, Umberto, Chiappella, Annalisa, Angelucci, Emanuele, Rossi, Giuseppe, Liberati, Anna Marina, Cabras, Maria Giuseppina, Botto, Barbara, Ciccone, Giovannino, Gaidano, Gianluca, Falchi, Lorenzo, Freilone, Roberto, Novero, Domenico, Orsucci, Lorella, Pavone, Vincenzo, Pogliani, Enrico, Rota-Scalabrini, Delia, Salvi, Flavia, Tonso, Anna, Tucci, Alessandra, Levis, Alessandro, on behalf of Gruppo Italiano Multiregionale Linfomi e Leucemie (GIMURELL)

“…1 SC Ematologia II, Azienda Ospedaliera e Universitaria San Giovanni Battista, Torino 2 SC Ematologia, Ospedale Oncologico di Riferimento Regionale Armando…”
Get full text

Effects of different doses of erythropoietin in patients with myelodysplastic syndromes: A propensity score‐matched analysis by Balleari, Enrico, Filiberti, Rosa Angela, Salvetti, Chiara, Allione, Bernardino, Angelucci, Emanuele, Bruzzone, Marco, Calzamiglia, Tullio, Cavaliere, Marina, Cavalleri, Maurizio, Cilloni, Daniela, Clavio, Marino, Crisà, Elena, Da Col, Anna, Danise, Paolo, Pilo, Federica, Ferrero, Dario, Finelli, Carlo, Gioia, Daniela, Lemoli, Roberto Massimo, Masiera, Elisa, Messa, Emanuela, Miglino, Maurizio, Musto, Pellegrino, Natalie Oliva, Esther, Poloni, Antonella, Salvi, Flavia, Sanna, Alessandro, Scudeletti, Marco, Tassara, Rodolfo, Santini, Valeria

“…Background Erythropoiesis‐stimulating agents effectively improve the hemoglobin levels in a fraction of anemic patients with myelodysplastic syndromes (MDS)…”
Get full text

Arsenic trioxide and ascorbic acid interfere with the BCL2 family genes in patients with myelodysplastic syndromes: an ex-vivo study by Galimberti, Sara, Guerrini, Francesca, Salvi, Flavia, Petrini, Iacopo, Gioia, Daniela, Messa, Emanuela, Palumbo, Giuseppe A, Cilloni, Daniela, Petrini, Mario, Levis, Alessandro

“…Arsenic Trioxide (ATO) is effective in about 20% of patients with myelodysplasia (MDS); its mechanisms of action have already been evaluated in vitro, but the…”
Get full text

Successful HLA haploidentical myeloablative stem cell transplantation for aggressive hepatosplenic alpha/beta (αβ) T-cell lymphoma by Catania, Gioacchino, Zallio, Francesco, Monaco, Federico, Corsetti, Maria Teresa, Trincheri, Nicol, Bonello, Lisa, Mele, Lia, Dallavalle, Franco, Salvi, Flavia, Pini, Massimo

“…Abstract Hepatosplenic T cell lymphoma (HSTCL) is a type of hematologic neoplasia with a poor prognosis and a high frequency of refractoriness to conventional…”
Get full text

Brentuximab vedotin in relapsed primary mediastinal large B-cell lymphoma: results from a phase 2 clinical trial by Zinzani, Pier Luigi, Pellegrini, Cinzia, Chiappella, Annalisa, Di Rocco, Alice, Salvi, Flavia, Cabras, Maria Giuseppina, Argnani, Lisa, Stefoni, Vittorio

Get full text

Long-Term Results of the FOLL05 Trial Comparing R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Symptomatic Follicular Lymphoma by Luminari, Stefano, Ferrari, Angela, Manni, Martina, Dondi, Alessandra, Chiarenza, Annalisa, Merli, Francesco, Rusconi, Chiara, Tarantino, Vittoria, Tucci, Alessandra, Vitolo, Umberto, Kovalchuk, Sofia, Angelucci, Emanuele, Pulsoni, Alessandro, Arcaini, Luca, Angrilli, Francesco, Gaidano, Gianluca, Stelitano, Caterina, Bertoldero, Giovanni, Cascavilla, Nicola, Salvi, Flavia, Ferreri, Andrés J M, Vallisa, Daniele, Marcheselli, Luigi, Federico, Massimo

“…Purpose The FOLL05 trial compared R-CVP (rituximab plus cyclophosphamide, vincristine, and prednisone) with R-CHOP (rituximab plus cyclophosphamide,…”
Get full text